ReviewCurrent hematologic malignancy reports2021
A New Target for Hodgkin Lymphoma - Camidanlumab Tesirine.
Narendranath Epperla et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewCurrent hematologic malignancy reports2021
Narendranath Epperla et al.PubMed ↗Publisher ↗
No numbers read from the abstract.